20:02 EST Cathie Wood’s ARK Investment buys 653K shares of Recursion Pharmaceuticals (RXRX) today
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Recursion Pharmaceuticals price target lowered to $10 from $12 at KeyBanc
- Recursion announces two oncology drugs advancing to clinical trials
- Recursion Pharmaceuticals price target lowered to $10 from $12 at BofA
- Recursion Pharmaceuticals CFO Ben Taylor to Join Exscientia
- Recursion Pharmaceuticals call volume above normal and directionally bullish